...
首页> 外文期刊>CNS spectrums >Measures of the DSM-5 mixed-features specifier of major depressive disorder
【24h】

Measures of the DSM-5 mixed-features specifier of major depressive disorder

机译:DSM-5混合特征的主要抑郁症的措施

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

During the past two decades, a number of studies have found that depressed patients frequently have manic symptoms intermixed with depressive symptoms. While the frequency of mixed syndromes are more common in bipolar than in unipolar depressives, mixed states are also common in patients withmajor depressive disorder. The admixture of symptoms may be evident when depressed patients present for treatment, or they may emerge during ongoing treatment. In some patients, treatment with antidepressant medication might precipitate the emergence of mixed states. It would therefore be useful to systematically inquire into the presence of manic/hypomanic symptoms in depressed patients. We can anticipate that increased attention will likely be given to mixed depression because of changes in the DSM-5. In the present article, I review instruments that have been utilized to assess the presence and severity of manic symptoms and therefore could be potentially used to identify the DSM-5 mixed-features specifier in depressed patients and to evaluate the course and outcome of treatment. In choosing which measure to use, clinicians and researchers should consider whether the measure assesses both depression and mania/hypomania, assesses all or only some of the DSM-5 criteria for the mixed-features specifier, or assesses manic/hypomanic symptoms that are not part of the DSM-5 definition. Feasibility, more so than reliability and validity, will likely determine whether these measures are incorporated into routine clinical practice.
机译:在过去的二十年中,一些研究发现,抑郁症患者经常具有令人抑制症状的躁狂症症状。虽然混合综合征的频率比双极抑郁症更常见,但混合状态也常见于抑郁症的患者。当抑郁症患者患者治疗时可能是显而易见的症状的混合物,或者在正在进行的治疗过程中可能出现。在一些患者中,用抗抑郁药物治疗可能会促使混合状态的出现。因此,系统地询问抑郁症患者中的躁狂/奇差症状的存在。由于DSM-5的变化,我们可以预测可能会给混合抑郁症发出更多的注意力。在本文中,我审查了用于评估躁狂症症状的存在和严重程度的仪器,因此可能用于识别抑制患者中的DSM-5混合特征,并评估治疗的课程和结果。在选择哪种措施时,临床医生和研究人员应考虑措施是否评估抑郁症和躁狂/丑人,评估混合特征说明符的所有或只有一些DSM-5标准,或评估不是DSM-5的一部分定义。可行性,更多的是可靠性和有效性,可能会确定这些措施是否纳入常规临床实践。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号